223 related articles for article (PubMed ID: 28081656)
1. Clinicopathological and biochemical findings of thyroid amyloid in hereditary transthyretin amyloidosis with and without liver transplantation.
Huang G; Ueda M; Tasaki M; Yamashita T; Misumi Y; Masuda T; Suenaga G; Inoue Y; Kinoshita Y; Matsumoto S; Mizukami M; Tsuda Y; Nomura T; Obayashi K; Ando Y
Amyloid; 2017 Mar; 24(1):24-29. PubMed ID: 28081656
[TBL] [Abstract][Full Text] [Related]
2. Marked biochemical difference in amyloid proportion between intra- and extraocular tissues in a liver-transplanted patient with hereditary ATTR amyloidosis.
Yoshinaga T; Yazaki M; Kametani F; Sekijima Y; Iesato Y; Miyahara T; Tsuchiya-Suzuki A; Sano K; Higuchi K; Ikeda SI
Amyloid; 2017 Mar; 24(1):17-23. PubMed ID: 28081655
[TBL] [Abstract][Full Text] [Related]
3. Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation.
Liepnieks JJ; Benson MD
Amyloid; 2007 Dec; 14(4):277-82. PubMed ID: 17968687
[TBL] [Abstract][Full Text] [Related]
4. Hereditary transthyretin amyloidosis: molecular basis and therapeutical strategies.
Saraiva MJ
Expert Rev Mol Med; 2002 May; 4(12):1-11. PubMed ID: 14987380
[TBL] [Abstract][Full Text] [Related]
5. A novel type of familial transthyretin amyloidosis, ATTR Asn124Ser, with co-localization of kappa light chains.
Bergström J; Patrosso MC; Colussi G; Salvadore M; Penco S; Lando G; Marocchi A; Ueda A; Nakamura M; Ando Y
Amyloid; 2007 Jun; 14(2):141-5. PubMed ID: 17577687
[TBL] [Abstract][Full Text] [Related]
6. Pathological changes long after liver transplantation in a familial amyloidotic polyneuropathy patient.
Obayashi K; Ueda M; Oshima T; Kawahara S; Misumi Y; Yamashita T; Jono H; Yazaki M; Kametani F; Ikeda S; Ohya Y; Asonuma K; Inomata Y; Ando Y
BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22907857
[TBL] [Abstract][Full Text] [Related]
7. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings.
Maia LF; Magalhães R; Freitas J; Taipa R; Pires MM; Osório H; Dias D; Pessegueiro H; Correia M; Coelho T
J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):159-67. PubMed ID: 25091367
[TBL] [Abstract][Full Text] [Related]
8. Changes in pathological and biochemical findings of systemic tissue sites in familial amyloid polyneuropathy more than 10 years after liver transplantation.
Oshima T; Kawahara S; Ueda M; Kawakami Y; Tanaka R; Okazaki T; Misumi Y; Obayashi K; Yamashita T; Ohya Y; Ihse E; Shinriki S; Tasaki M; Jono H; Asonuma K; Inomata Y; Westermark P; Ando Y
J Neurol Neurosurg Psychiatry; 2014 Jul; 85(7):740-6. PubMed ID: 24023270
[TBL] [Abstract][Full Text] [Related]
9. α-Synuclein aggregation in the saliva of familial transthyretin amyloidosis: a potential biomarker.
Guerreiro A; da Costa G; Gomes RA; Ribeiro-Silva C; Gilberto S; Mateus E; Monteiro E; Barroso E; Coelho AV; Ponces Freire A; Cordeiro C
Amyloid; 2012 Jun; 19(2):74-80. PubMed ID: 22591216
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of germline mutations in the TTR gene in a consecutive series of surgical pathology specimens with ATTR amyloid.
Eriksson M; Büttner J; Todorov T; Yumlu S; Schönland S; Hegenbart U; Kristen AV; Dengler T; Lohse P; Helmke B; Schmidt H; Röcken C
Am J Surg Pathol; 2009 Jan; 33(1):58-65. PubMed ID: 18830126
[TBL] [Abstract][Full Text] [Related]
11. Aging and transthyretin-related amyloidosis: pathologic examinations in pulmonary amyloidosis.
Ueda M; Ando Y; Haraoka K; Katsuragi S; Terasaki Y; Sugimoto M; Sun X; Uchino M
Amyloid; 2006 Mar; 13(1):24-30. PubMed ID: 16690497
[TBL] [Abstract][Full Text] [Related]
12. The relative amounts of plasma transthyretin forms in familial transthyretin amyloidosis: a quantitative analysis by Fourier transform ion-cyclotron resonance mass spectrometry.
Ribeiro-Silva C; Gilberto S; Gomes RA; Mateus É; Monteiro E; Barroso E; Coelho AV; da Costa G; Freire AP; Cordeiro C
Amyloid; 2011 Dec; 18(4):191-9. PubMed ID: 22080762
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of long-term diflunisal administration in hereditary transthyretin (ATTR) amyloidosis.
Sekijima Y; Tojo K; Morita H; Koyama J; Ikeda S
Amyloid; 2015; 22(2):79-83. PubMed ID: 26017328
[TBL] [Abstract][Full Text] [Related]
14. Proportion between wild-type and mutant protein in truncated compared to full-length ATTR: an analysis on transplanted transthyretin T60A amyloidosis patients.
Ihse E; Stangou AJ; Heaton ND; O'Grady J; Ybo A; Hellman U; Edvinsson A; Westermark P
Biochem Biophys Res Commun; 2009 Feb; 379(4):846-50. PubMed ID: 19118530
[TBL] [Abstract][Full Text] [Related]
15. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
Sekijima Y
J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and therapeutic approaches to transthyretin amyloidosis.
Ando Y; Ueda M
Curr Med Chem; 2012; 19(15):2312-23. PubMed ID: 22471980
[TBL] [Abstract][Full Text] [Related]
17. Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis.
Ihse E; Suhr OB; Hellman U; Westermark P
J Mol Med (Berl); 2011 Feb; 89(2):171-80. PubMed ID: 21107516
[TBL] [Abstract][Full Text] [Related]
18. Liver transplantation in transthyretin amyloidosis: issues and challenges.
Carvalho A; Rocha A; Lobato L
Liver Transpl; 2015 Mar; 21(3):282-92. PubMed ID: 25482846
[TBL] [Abstract][Full Text] [Related]
19. Liver transplantation for hereditary transthyretin amyloidosis.
Suhr OB; Herlenius G; Friman S; Ericzon BG
Liver Transpl; 2000 May; 6(3):263-76. PubMed ID: 10827225
[TBL] [Abstract][Full Text] [Related]
20. Transthyretin: Its function and amyloid formation.
Ueda M
Neurochem Int; 2022 May; 155():105313. PubMed ID: 35218869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
